Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-007483

President and CEO sold 18,334 shares at an average $18.72 ($343,300)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2019-02-01 Sale −6,050 $18.65 $112,833 2,646,588 I
Watts Ryan J. President and CEO 2019-02-04 Sale −3,200 $18.49 $59,168 2,643,388 I
Watts Ryan J. President and CEO 2019-02-04 Sale −854 $19.12 $16,328 2,642,534 I
Watts Ryan J. President and CEO 2019-02-05 Sale −8,230 $18.83 $154,971 2,634,304 I
Open-market sales · 18,334 sh · avg $18.72 · $343,300
Loading xslF345X03/doc4.xml…